Indication intelligence, analysis and sector perception

RegMed Investors’ (RMi): worried about 2019, investors better be!

January 21, 2019 6:22am

RMi is the source investors and traders need – it’s more than opinion; the facts and truth need to be recognized!

I post about “indication intelligence” devoting my time to collection and analysis of information for insight into sector vulnerabilities and strengths.

My writing is “that warning analysis is NOT a commodity.

However, there are times, when the likelihood of conclusions are inescapable!

http://www.regmedinvestors.com/create-account

Our hit/miss batting average well exceeds ... 82%.

Can you do better elsewhere?

THE reason to subscribe to RMi …it’s been a choppy year!

Volatility, news. rumors and "runways" i.e. cash positions along with who needs to “tap” the capital markets for continued survival?

How are enrollments going as to population and are they sustainable re drop-outs?

Has the data from on-going trials been interpreted as to render measureable and definitive outcomes? Is the company partnered to ward-off the issues of dilution and share depreciation!

And finally, trend analysis – does momentum’s magnitude, technicals and fundamentals indicate expected pricing performance in 2019?

Why spend time finding sector news and analytics … it’s all right here! Review daily indicators, factors and trend lines, advance/decline lines, pre-open indicator results and volatility and of the % count of decliners versus gainers.

Learn who is stumbling and what the mumbling means …

SUBSCRIBE ... for continued access to what one industry CEO calls the “Bible” for smart investing in the RegMed, gene and cell therapy sector

Click on the BUY button: http://www.regmedinvestors.com/create-account

My motto: Never leave an investor uninformed!

35 companies, 1 interpreter!

Insight, foresight and recommendation

What's Happening Today

3 hours 41 min ago
RegMed Investors (RMi) Closing Bell: I told you so

12 hours 29 min ago
RegMed Investors’ (RMi) pre-open: It’s “make” a buck day!

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.